Resistance of Yersinia pestis to Antimicrobial Agents-Reference-Cited by-同舟云学术

Resistance of Yersinia pestis to Antimicrobial Agents

Published:2006-10 Issue:10 Volume:50 Page:3233-3236
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Galimand Marc¹,Carniel Elisabeth²,Courvalin Patrice¹

Affiliation:

1. Unité des Agents Antibactériens, and Yersinia Research Unit, National Reference Laboratory

2. WHO Collaborating Center for Yersinia, Institut Pasteur, Paris, France

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00306-06

Reference28 articles.

1. Bames, A. M., and T. J. Quan. 1992. Plague, p 1285-1291. In S. L. Gorbach, J. G. Bartlett, and N. R. Blacklow (ed.), Infectious diseases. W. B. Saunders Company. Philadelphia, Pa.

2. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection

3. Bossi, P., A. Tegnell, A. Baka, F. Van Loock, J. Hendriks, A. Werner, H. Maidhof, and G. Gouvras. December 2004. Bichat guidelines for the clinical management of plague and bioterrorism-related plague. Euro. Surveill.9:12. [Online.] http://www.eurosurveillance.org/em/v09n12/0912-232.asp

4. Boulanger, L. L., P. Ettestad, J. D. Fogarty, D. T. Dennis, D. Romig, and G. Mertz. 2004. Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985-1999. Clin. Infect. Dis.38:663-669.

5. Antibiotic Treatment of Experimental Pneumonic Plague in Mice

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress on the research and development of plague vaccines with a call to action;npj Vaccines;2024-09-07

2. Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potential;PLOS ONE;2024-07-02

3. Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics;Cell Host & Microbe;2024-06

4. Nanotherapeutics for Bacterial Livestock Diseases;Livestock Diseases and Management;2024

5. Pathogenic Microbial Genetic Diversity With Reference to Significant Medical and Public Health;Microbial Diversity in the Genomic Era;2024